Table 2.
Baseline | Day 28 | 3 Month | |
---|---|---|---|
GMT | |||
A/H1N1 | 29.1 | 65.6 | 62 |
A/H3N2 | 26.9 | 46.9 | 42.9 |
B | 30.9 | 48.8 | 49.2 |
Seroconversion | |||
A/H1N1 | 37.1% | ||
A/H3N2 | 22.9% | ||
B | 22.9% | ||
Seroprotection | |||
A/H1N1 | 45.7% | 80.0% | 73.3% |
A/H3N2 | 26.9% | 68.6% | 56.7% |
B | 51.4% | 74.3% | 66.7% |
Serologic response to trivalent inactivated influenza vaccination including geometric mean titer (GMT), seroconversion (at day 28) and seroprotection.